RDLA applauds the House for approving the 21st Century Cures Act by a strong, bipartisan vote of 344 to 77. This landmark legislation will spur scientific discovery and bio-medical innovation, providing hope for patients and their families, while also protecting jobs and America’s leadership role in healthcare innovation.
Attention now turns to the Senate, and we look forward to working with Senators on their ideas and priorities for creating treatments and cures for rare diseases. We encourage the Senate to move quickly in advancing this legislation through the chamber and to the president’s desk.
If you’d like to know more about the contents of the 21st Century Cures Act, click here for our information page on the legislation.